Robeco Institutional Asset Management B.V. Has $1.36 Million Stock Holdings in The Cooper Companies, Inc. (NASDAQ:COO)

Robeco Institutional Asset Management B.V. cut its holdings in shares of The Cooper Companies, Inc. (NASDAQ:COO - Free Report) by 21.8% during the 1st quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 16,108 shares of the medical device company's stock after selling 4,478 shares during the quarter. Robeco Institutional Asset Management B.V.'s holdings in Cooper Companies were worth $1,359,000 at the end of the most recent reporting period.

Several other institutional investors and hedge funds have also recently added to or reduced their stakes in the business. OFI Invest Asset Management bought a new stake in shares of Cooper Companies in the 4th quarter valued at about $34,000. City Holding Co. bought a new stake in shares of Cooper Companies in the 1st quarter valued at about $34,000. New Age Alpha Advisors LLC bought a new stake in shares of Cooper Companies in the 4th quarter valued at about $38,000. Covestor Ltd raised its holdings in shares of Cooper Companies by 35.5% in the 4th quarter. Covestor Ltd now owns 458 shares of the medical device company's stock valued at $42,000 after purchasing an additional 120 shares during the period. Finally, Atala Financial Inc bought a new stake in shares of Cooper Companies in the 4th quarter valued at about $51,000. 24.39% of the stock is owned by institutional investors.

Cooper Companies Stock Performance

Shares of NASDAQ:COO traded down $0.01 on Friday, reaching $73.01. 1,492,346 shares of the company's stock were exchanged, compared to its average volume of 1,712,347. The company has a fifty day moving average of $75.62 and a 200-day moving average of $83.26. The Cooper Companies, Inc. has a twelve month low of $65.00 and a twelve month high of $112.38. The company has a market capitalization of $14.60 billion, a price-to-earnings ratio of 35.44, a PEG ratio of 1.79 and a beta of 0.99. The company has a current ratio of 2.10, a quick ratio of 1.23 and a debt-to-equity ratio of 0.30.

Cooper Companies (NASDAQ:COO - Get Free Report) last announced its earnings results on Thursday, May 29th. The medical device company reported $0.96 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $0.93 by $0.03. Cooper Companies had a net margin of 10.39% and a return on equity of 9.60%. The firm had revenue of $1 billion for the quarter, compared to analyst estimates of $995.12 million. During the same quarter in the prior year, the business posted $0.85 EPS. The business's revenue was up 6.3% compared to the same quarter last year. On average, research analysts predict that The Cooper Companies, Inc. will post 3.98 EPS for the current fiscal year.

Analyst Upgrades and Downgrades

A number of equities research analysts have recently issued reports on the stock. Stifel Nicolaus dropped their target price on shares of Cooper Companies from $115.00 to $105.00 and set a "buy" rating on the stock in a report on Friday, March 7th. JPMorgan Chase & Co. reiterated a "neutral" rating and issued a $76.00 price target (down previously from $110.00) on shares of Cooper Companies in a research note on Friday, May 30th. Wall Street Zen upgraded shares of Cooper Companies from a "hold" rating to a "buy" rating in a research note on Friday, June 27th. Citigroup decreased their price target on shares of Cooper Companies from $115.00 to $110.00 and set a "buy" rating on the stock in a research note on Friday, March 7th. Finally, Needham & Company LLC upgraded shares of Cooper Companies from a "hold" rating to a "buy" rating and set a $94.00 price target on the stock in a research note on Tuesday, June 17th. Three investment analysts have rated the stock with a hold rating and nine have assigned a buy rating to the company's stock. According to MarketBeat.com, the company presently has an average rating of "Moderate Buy" and a consensus price target of $99.70.

Cooper Companies Profile

The Cooper Companies, Inc, together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment provides spherical lense, including lenses that correct near and farsightedness; and toric and multifocal lenses comprising lenses correcting vision challenges, such as astigmatism, presbyopia, and myopia in the Americas, Europe, Middle East, Africa, and Asia Pacific.